UK markets closed

ZIOPHARM Oncology, Inc. (WEK.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.41000.0000 (0.00%)
As of 08:10AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-26,774
-35,140
-37,730
-78,751
-79,976
Depreciation & amortisation
1,621
2,315
2,759
2,597
1,128
Stock-based compensation
2,062
2,800
3,528
10,774
6,829
Change in working capital
-5,139
-6,254
870
3,141
15,006
Accounts payable
-682
-773
-25
274
54
Other working capital
-22,814
-30,339
-29,448
-64,791
-66,791
Other non-cash items
-
1,327
1,334
31
-
Net cash provided by operating activities
-22,678
-30,142
-29,232
-61,468
-57,013
Cash flows from investing activities
Investments in property, plant and equipment
-
-197
-216
-3,323
-9,778
Net cash used for investing activities
1,369
1,346
-193
-3,323
-9,778
Cash flows from financing activities
Debt repayment
-11,855
-18,105
-8,333
0
-
Common stock issued
0
92
14,724
0
101,677
Common stock repurchased
-
0
-45
0
0
Other financing activities
-
-125
-
-260
-
Net cash used provided by (used for) financing activities
-11,980
-18,138
6,367
25,776
102,119
Net change in cash
-33,289
-46,934
-23,058
-39,015
35,328
Cash at beginning of period
37,434
52,996
76,054
115,069
79,741
Cash at end of period
4,145
6,062
52,996
76,054
115,069
Free cash flow
Operating cash flow
-22,678
-30,142
-29,232
-61,468
-57,013
Capital expenditure
-
-197
-216
-3,323
-9,778
Free cash flow
-22,814
-30,339
-29,448
-64,791
-66,791